EREmily D. Rout

Emily D. Rout

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emily D. Rout has a total of 142 co-authors. Here are the top co-authors by number of shared publications:

  • Anne C. Avery

    Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA

    12 shared publications
  • A. Russell Moore

    Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences Colorado State University Fort Collins Colorado USA

    7 shared publications
  • Janna A. Yoshimoto

    Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Microbiology Fort Collins, Colorado

    6 shared publications
  • Paul R. Avery

    Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences Colorado State University Fort Collins Colorado USA

    6 shared publications
  • Anne C. Avery

    Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado

    5 shared publications
  • Robert Adam Harris

    Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences Colorado State University Fort Collins Colorado USA

    5 shared publications

Latest Publications

  • Open Access

    Multi-omic longitudinal profiling of companion dogs reveals cross-omic coordination and structured aging trajectories

    by Tal Bamberger, Yadid M. Algavi, Efrat Muller, Omri Peleg, Shiri Baum, Ashlee Greenier, Christine Adjangba, Elizabeth Slikas, Layla Brassington, Blaise Mariner, et al.

    Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap, combining shared human environments with diversity in genetics, lifespan, and disease susceptibility. Here, we present a longitudinal multi-omic analysis of aging in 965 companion dogs from the Dog Aging Project, integrating microbiome, epigenome, blood metabolome, and immune phenotyping with extensive clinical, environmental, and lifestyle surveys. We reveal an interconnected cross-omic architecture, with age emerging as the dominant axis of biological variation. We further identify a predictive multi-omic aging signature, distinguish linear from non-linear aging trajectories, uncover breed size-dependent dynamics, and characterize omic-specific mortality risk. Collectively, our findings reveal organizing principles of aging, many paralleling human observations, provide a unique resource for integrative geroscience, and establish dogs as a translational model for aging research.

  • Epigenetic aging and transposon dysregulation reflect size-related lifespan compression in dogs

    by Blaise L. Mariner, Brianah M. McCoy, Ashlee Greenier, Layla Brassington, Elizabeth Slikas, Christine Adjangba, Claire Cheng, Abbey Marye, Benjamin R. Harrison, Tal Bamberger, et al.

    The extraordinary lifespan variation in domestic dogs provides a natural experiment for testing how intrinsic rates of biological aging shape lifespan. Using 1640 methylomes from 894 dogs, we developed an epigenetic clock that predicted mortality and demonstrated that epigenetic aging is fastest early in life. At orthologs of human age-associated genes, dogs exhibited concordant age effects on promoter methylation, highlighting conserved remodeling of immune pathways. We found that larger and male dogs, which are shorter lived, exhibit accelerated molecular aging. Distinct epigenetic architectures mediated these effects: Sex-dependent methylation changes were concentrated on the X chromosome, whereas size-associated methylation was especially pronounced at transposable elements (TEs). These findings show that epigenetics reflects lifespan differences in dogs and identifies TEs as potential mediators of size-associated lifespan.


  • Open Access

    What Is Your Diagnosis? Lymph Node Aspirate From a Dog

    by William Benedict, Emily Rout, Lori Cesario, A Russell Moore

  • Open Access

    Messenger RNA From Canine Cytology Lymph Node Specimens Can Be Utilised for Gene Expression Profiling Using Digital RNA Counting

    by McKenzie Olsen, Emily Rout, Kelly Hughes, Janna Yoshimoto, Anne Avery, R. Adam Harris

    Gene expression profiling (GEP) is being used with increasing frequency to characterise canine tumours, but canine samples are often not collected in a medium to preserve RNA. Cytology samples from human tumours have been shown to provide adequate RNA for GEP using NanoString nCounter technology, suggesting a similar approach might be viable for canine samples. Determine the quantity and quality of RNA extracted from canine cytology slides, evaluate the time frame for RNA integrity and assess the utility of performing GEP with extracted RNA. Cytological specimens were derived from reactive lymph nodes ( n = 10) and lymphoma cases ( n = 34) and characterised via flow cytometry or PCR for antigen receptor rearrangements. RNA was extracted from stained and unstained lymph node cytology slides using a RNeasy Mini Kit and subsequently evaluated for quality and quantity. GEP was carried out using nCounter technology with the NanoString Canine IO Panel. Extracted RNA from lymphoma and reactive cytology samples generated concentrations ranging from 27.5 to 543.9 ng/μL (median: 168.5 ng/μL; interquartile range (IQR): 108.15–275.95 ng/μL). RNA integrity numbers (RINs) ranged from 1.0 to 7.2 (median: 2.9; IQR: 2.10–4.45) and DV200 values ranged from 50.5% to 93.2% (median: 81.65%; IQR: 71.95%–87.85%). RIN and DV200 values were highest for extractions within 7 days of sample collection. GEP revealed overexpression of 17 genes in lymphoma samples such as MYC, TERT and BRCA2. Canine lymph node cytologic specimens provide sufficient RNA quality for GEP. The nCounter Canine IO Panel demonstrates the utility of cytology specimens for evaluating gene expression.

  • Open Access

    What Is Your Diagnosis? Lymph Node Aspirates From a Dog

    by Gillian Herbert, Kristina Meichner, Emily Rout, Troy Myers, Mackenzie Long

  • Open Access

    Utility of Cytochemical and Flow Cytometry Detection of Alkaline Phosphatase for Differential Diagnosis of CD34 + Acute Leukaemia in Canines

    by Megan Aalto, Janna Yoshimoto, Jillian Nolan, Kenzie Olsen, Dylan Ammons, Emily Rout, Anne C. Avery, R. Adam Harris

    Alkaline phosphatase (ALP) enzymatic activity has been proposed as a marker for distinguishing canine acute leukaemia (AL) subtypes (i.e., myeloid vs. lymphoid). However, ALP enzymatic activity has not been fully evaluated in CD34+ AL. Determine whether ALP enzymatic activity can differentiate CD34+ AL subtypes in dogs and distinguish CD34+ AL from CD34− haematopoietic tumours in tissue/effusion samples. Peripheral blood from 64 dogs with CD34+ AL, 10 with B cell chronic lymphocytic leukaemia (CLL), and 10 healthy controls were prospectively evaluated for ALP enzymatic activity via cytochemical staining; a subset also underwent ALP detection by flow cytometry (FC). Archived cytology slides from 67 tissue/effusion specimens, including 27 CD34+ AL, 22 T cell lymphomas, and 18 B cell lymphomas, were retrospectively assessed. CD34+ AL cases were categorised as acute myeloid leukaemia (AML), acute lymphoid leukaemia (ALL) or acute unclassifiable leukaemia (AUL) by established FC criteria. ALP positivity was defined as > 3% ALP+ neoplastic cells, which was selected based on receiver operating characteristic (ROC) curve analysis. Cytochemical ALP activity was detected in 61/64 (95.3%) CD34+ AL cases, with no significant differences between AML, ALL, and AUL subtypes ( p > 0.05). All lymphoma and B cell CLL cases were ALP‐negative. FC‐based ALP analysis showed poor concordance with cytochemistry, and the correlation between %CD34 + ALP+ cells and %ALP+ neoplastic cells was weak (Spearman's ρ = 0.25). While ALP enzymatic activity is present in most CD34+ AL cases, it does not reliably differentiate CD34+ AL subtypes via cytochemistry. However, ALP may help distinguish CD34+ AL from B and T cell lymphomas. FC‐based ALP analysis is not a reliable marker for CD34+ AL classification.


  • Open Access

    Diagnostic Sensitivity of the PCR for Antigen Receptor Rearrangement (PARR) Assay for Canine Plasma Cell Tumors

    by Emily D. Rout, Kacie Seymour, Robert Burnett, Cora Contreras, Anne C. Avery, A Russell Moore

    Background: The PCR for Antigen Receptor Rearrangement (PARR) assay assesses clonality of a lymphoid population. Studies suggest PARR has decreased sensitivity for detecting clonality in canine plasma cell tumors (PCT) compared to lymphoma.Objective: Assess sensitivity of PARR assays targeting the immunoglobulin heavy chain (IGH), immunoglobulin lambda light chain (IGL), and kappa deleting element (Kde) loci in canine PCT.Methods: Canine cases included 35 PCTs (multiple myeloma and extramedullary, cutaneous or oral PCTs), 5 non‐PCT foil cases, and 40 B‐cell lymphoma cases. PCT diagnoses were confirmed via CD3, PAX5, and MUM1 immunolabeling, and some additionally had histopathology, serum or urine protein electrophoresis, or immunofixation. Nodal B‐cell lymphomas were diagnosed by flow cytometry. Routine PARR (targeting IGH V‐D‐J and D‐J rearrangements) and extended PARR (targeting additional IGH genes and IGL and Kde rearrangements) were performed on cytologic specimens (PCT and foil cases) and flow cytometry aspirates (lymphoma cases). Diagnostic sensitivity was calculated.Results: Across both PARR assays, every PCT case with sufficient sample was interpreted as clonal and no foil cases were clonal. The routine PARR assay detected a clonal immunoglobulin rearrangement in 26/35 PCT cases (74.3%; 95% CI 56.7%–87.5%). The extended assay detected immunoglobulin gene clonality in 33/35 PCT cases (94.3%; 95% CI 80.8%–99.3%). 40/40 lymphoma cases were clonal in both the routine and extended PARR assays.Conclusion: The combined PARR assays used in this study, evaluating multiple IG loci, detected clonality in all PCTs tested, but routine PARR (targeting IGH) was less sensitive for detecting PCT clonality compared to B‐cell lymphomas.


  • JoVE Video Dataset

    by Mary-Keara Boss, Braden Burdekin, Lauren Harrison, Madison Rivera, Adam Harris, Emily Rout, Erin Trageser, Patricia Gualtieri, Ber-In Lee, Steven Dow

    Evaluating the local immune microenvironment of the canine nasal cavity can be important for investigating normal tissue health and disease conditions, particularly those associated with local inflammation. We have optimized a technique to evaluate the local nasal immune microenvironment of dogs via serial nasal lavage. Briefly, with dogs under anesthesia and positioned in sternal recumbency, prewarmed sterile saline is flushed into the affected nostril using a flexible soft rubber catheter. The fluid backflow is collected into conical tubes, and this process is repeated. The fluids containing dislodged cells and proteins are pooled, and the pooled nasal lavage samples are filtered through a cell strainer to remove large debris and mucus. Samples are centrifuged and the cell pellets are isolated for analysis. Once the samples have been processed, analyses that may follow nasal lavage include flow cytometry, transcriptomic analysis of cells via bulk or single-cell RNA seq, and/or quantification of cytokines present in the lavage fluid.

  • Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

    by Mary-Keara Boss, Braden Burdekin, Lauren Harrison, Madison Rivera, Adam Harris, Emily Rout, Erin Trageser, Patricia Gualtieri, Ber-In Lee, Steven Dow

    Evaluating the local immune microenvironment of the canine nasal cavity can be important for investigating normal tissue health and disease conditions, particularly those associated with local inflammation. We have optimized a technique to evaluate the local nasal immune microenvironment of dogs via serial nasal lavage. Briefly, with dogs under anesthesia and positioned in sternal recumbency, prewarmed sterile saline is flushed into the affected nostril using a flexible soft rubber catheter. The fluid backflow is collected into conical tubes, and this process is repeated. The fluids containing dislodged cells and proteins are pooled, and the pooled nasal lavage samples are filtered through a cell strainer to remove large debris and mucus. Samples are centrifuged and the cell pellets are isolated for analysis. Once the samples have been processed, analyses that may follow nasal lavage include flow cytometry, transcriptomic analysis of cells via bulk or single-cell RNA seq, and/or quantification of cytokines present in the lavage fluid.


  • Open Access

    Mapping the canine microbiome: Insights from the Dog Aging Project

    by Tal Bamberger, Efrat Muller, Yadid M. Algavi, Ashlee Greenier, Christine Adjangba, Elizabeth Slikas, Layla Brassington, Blaise Mariner, Brianah McCoy, Benjamin R. Harrison, et al.

    Companion dogs ( Canis lupus familiaris ) offer a unique model for studying the gut microbiome and its relation to aging due to their cohabitation with humans, sharing similar environments, diets, and healthcare practices. Here, we present the Dog Aging Project (DAP) Precision cohort, the largest population-wide study of the canine gut microbiome to date. This cohort encompasses over 900 dogs of diverse breeds, environments, and demographics living across the United States. Coupling fecal shotgun metagenomic sequencing with comprehensive phenotypic and environmental surveys and clinical lab tests, we explore the intricate relationships between microbiome composition, aging, and key factors such as diet, health, and living conditions. Our analyses identify various factors associated with microbiome composition. In addition, we find a gradual shift in microbiome composition with age, which allows us to develop a novel metagenomics-based “clock” to predict biological aging based on microbial signatures. Overall, these findings provide an unprecedented and detailed understanding of the role the gut microbiome plays in our four-legged companions, offering both potential applications in veterinary medicine and an exciting model for aging research.